By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cisbio will distribute Multispan's cell line portfolio in the US, under an agreement announced today by the firms.

The deal covers Multispan's cell line platform of more than 320 human and 209 rodent expression-ready cDNAs and 240 stable cell lines. The cell lines express G-protein coupled receptors in their native forms and "enable comprehensive investigation of effects of drug candidates on downstream signaling of each GPCR," the firms said in a joint statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.